Hennekens C H, Speizer F E, Lipnick R J, Rosner B, Bain C, Belanger C, Stampfer M J, Willett W, Peto R
J Natl Cancer Inst. 1984 Jan;72(1):39-42. doi: 10.1093/jnci/72.1.39.
Among 989 cases of breast cancer and 9,890 controls selected from a cohort of married, female registered nurses aged 30-55 years, the relative risk (RR) of breast cancer for women who had ever used oral contraceptives (OC) compared with those who had never used them was 1.0, with 95% confidence limits 0.9-1.2. Among OC users, there was no consistent pattern of excess risk with increasing duration; in fact, the few women who had used OC longest (greater than 10 yr) had a slightly lower risk than never-users. Moreover, there was no association between OC use and breast cancer among women with a positive history of breast cancer in the mother or sister or with OC use before their first pregnancy. The only subgroup of women among whom any adverse effect was apparent was current OC users aged 50-55 years (two onsets expected vs. seven observed). This finding is consistent with earlier reports of an increased risk of breast cancer among older OC users; however, it is also likely to reflect, at least to some extent, the play of chance, since at ages 45-49 and in each younger age group fewer cases than expected were observed among current OC users.
在从年龄为30至55岁的已婚女性注册护士队列中选取的989例乳腺癌患者和9890名对照中,曾经使用口服避孕药(OC)的女性患乳腺癌的相对风险(RR)与从未使用过的女性相比为1.0,95%置信区间为0.9至1.2。在口服避孕药使用者中,随着使用时间延长,不存在一致的额外风险模式;事实上,少数使用口服避孕药时间最长(超过10年)的女性风险略低于从未使用者。此外,在母亲或姐妹有乳腺癌阳性病史的女性中,或在首次怀孕前使用口服避孕药的女性中,口服避孕药使用与乳腺癌之间没有关联。唯一出现明显不良影响的女性亚组是年龄为50至55岁的当前口服避孕药使用者(预期发病2例,观察到7例)。这一发现与早期关于老年口服避孕药使用者患乳腺癌风险增加的报告一致;然而,这也至少在一定程度上可能反映了偶然性,因为在45至49岁以及每个更年轻的年龄组中,当前口服避孕药使用者中观察到的病例数少于预期。